Monocyte chemoattractant protein-1 is related to metabolic syndrome and homocysteine in subjects without clinically significant atherosclerotic cardiovascular disease

被引:19
作者
Kim, Sang-Hwan [2 ]
Lee, Ji-Won [3 ]
Im, Jee-Aee [1 ]
Hwang, Hee-Jin [2 ]
机构
[1] INTOTO Inc, Sport & Med Res Ctr, Seoul, South Korea
[2] Kwandong Univ, Dept Family Med, Myongji Hosp, Coll Med, Goyang, South Korea
[3] Yonsei Univ, Coll Med, Dept Family Med, Severance Hosp, Seoul, South Korea
关键词
ACUTE CORONARY SYNDROMES; CIRCULATING LEVELS; MONICA/KORA AUGSBURG; INSULIN-RESISTANCE; KORA S4; CHEMOKINES; INTERLEUKIN-8; INFLAMMATION; ASSOCIATION; OBESITY;
D O I
10.3109/00365513.2010.519047
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background. The features of the metabolic syndrome include glucose intolerance, hypertension, dyslipidemia, and central obesity, all of which are risk factors for diabetes and cardiovascular disease. Monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8) play a key role in atherosclerosis. We examined the association between chemokines, such as MCP-1 and IL-8, and metabolic syndrome. Methods. The present study was comprised of 54 men and 126 women. Subjects with cardiovascular disease such as myocardial infarction, TIA and cerebral infarction were excluded. Results. MCP-1 was positively correlated with homeostasis model assessment of insulin resistance, homocysteine, and mean pulse wave velocity, but IL-8 was not. In multiple regression analysis, age, HOMA-IR and homocysteine were found to be an independent factor associated with MCP-1 adjusted by gender, waist, systolic blood pressure, triglyceride, HDL-cholesterol, and hs-CRP. After adjustment for age and gender, mean MCP-1 was higher in subjects with metabolic syndrome and in subject with high blood pressure among the individual components of the metabolic syndrome. Conclusion. MCP-1 was associated with a low-grade systemic inflammatory reaction which is often found in the metabolic syndrome.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 41 条
[1]  
[Anonymous], 2001, JAMA, V285, P2486
[2]   Interaction between chemokines and oxidative stress:: Possible pathogenic role in acute coronary syndromes [J].
Aukrust, P ;
Berge, RK ;
Ueland, T ;
Aaser, E ;
Damås, JK ;
Wikeby, L ;
Brunsvig, A ;
Müller, F ;
Forfang, K ;
Froland, SS ;
Gullestad, L .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) :485-491
[3]   NEUTROPHIL-ACTIVATING PEPTIDE-1 INTERLEUKIN-8, A NOVEL CYTOKINE THAT ACTIVATES NEUTROPHILS [J].
BAGGIOLINI, M ;
WALZ, A ;
KUNKEL, SL .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (04) :1045-1049
[4]   Modulation of atherogenesis by chemokines [J].
Boisvert, WA .
TRENDS IN CARDIOVASCULAR MEDICINE, 2004, 14 (04) :161-165
[5]   Association between measures of insulin sensitivity and circulating levels of interleukin-8, interleukin-6 and tumor necrosis factor-α.: Effect of weight loss in obese men [J].
Bruun, JM ;
Verdich, C ;
Toubro, S ;
Astrup, A ;
Richelsen, B .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2003, 148 (05) :535-542
[6]   Metabolic syndrome - A comprehensive perspective based on interactions between obesity, diabetes, and inflammation [J].
Dandona, P ;
Aljada, A ;
Chaudhuri, A ;
Mohanty, P ;
Garg, R .
CIRCULATION, 2005, 111 (11) :1448-1454
[7]   Hyperhomocysteinemia and its role in the development of atherosclerosis [J].
de Koning, ABL ;
Werstuck, GH ;
Zhou, J ;
Austin, RC .
CLINICAL BIOCHEMISTRY, 2003, 36 (06) :431-441
[8]   Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes [J].
de Lemos, JA ;
Morrow, DA ;
Sabatine, MS ;
Murphy, SA ;
Gibson, CM ;
Antman, EM ;
McCabe, CH ;
Cannon, CP ;
Braunwald, E .
CIRCULATION, 2003, 107 (05) :690-695
[9]  
DEFZO RA, 1991, DIABETES CARE, V14, P173
[10]   HYPERINSULINEMIA - THE KEY FEATURE OF A CARDIOVASCULAR AND METABOLIC SYNDROME [J].
FERRANNINI, E ;
HAFFNER, SM ;
MITCHELL, BD ;
STERN, MP .
DIABETOLOGIA, 1991, 34 (06) :416-422